BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31532808)

  • 1. Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study.
    Page CM; Ibrahim S; Park LP; Huchko MJ
    PLoS One; 2019; 14(9):e0222750. PubMed ID: 31532808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems-level barriers to treatment in a cervical cancer prevention program in Kenya: Several observational studies.
    Page CM; Ibrahim S; Park LP; Huchko MJ
    PLoS One; 2020; 15(7):e0235264. PubMed ID: 32658921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya.
    Huchko MJ; Ibrahim S; Blat C; Cohen CR; Smith JS; Hiatt RA; Bukusi E
    Int J Gynaecol Obstet; 2018 Apr; 141(1):63-69. PubMed ID: 29197067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya.
    Huchko MJ; Kahn JG; Smith JS; Hiatt RA; Cohen CR; Bukusi E
    BMC Cancer; 2017 Dec; 17(1):826. PubMed ID: 29207966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A community-based, cross-sectional study of hrHPV DNA self-sampling-based cervical cancer screening in rural Karnataka, India.
    Adsul P; Srinivas V; Gowda S; Nayaka S; Pramathesh R; Chandrappa K; Khan A; Jayakrishna P; Madhivanan P
    Int J Gynaecol Obstet; 2019 Aug; 146(2):170-176. PubMed ID: 31074835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of text message reminders on cryotherapy uptake among women testing positive for HPV in western Kenya: a prospective cohort study.
    Choi Y; Ibrahim S; Park LP; Bukusi EA; Huchko MJ
    BMC Womens Health; 2024 Jan; 24(1):32. PubMed ID: 38218782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
    JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach.
    Mungo C; Ibrahim S; Bukusi EA; Truong HM; Cohen CR; Huchko M
    Int J Gynaecol Obstet; 2021 Jan; 152(1):60-67. PubMed ID: 32347550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya.
    Shen J; Olwanda E; Kahn JG; Huchko MJ
    BMC Health Serv Res; 2018 May; 18(1):378. PubMed ID: 29801496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
    Nishino HT; Tambouret RH; Wilbur DC
    Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 13. 'I'm here to save my life': a qualitative study of experiences navigating a cryotherapy referral system for human papillomavirus-positive women in western Kenya.
    Huchko M; Adewumi K; Oketch S; Saduma I; Bukusi E
    BMJ Open; 2019 Jul; 9(7):e028669. PubMed ID: 31345973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile Phone Ownership and Use Among Women Screening for Cervical Cancer in a Community-Based Setting in Western Kenya: Observational Study.
    Stocks J; Ibrahim S; Park L; Huchko M
    JMIR Public Health Surveill; 2022 Jun; 8(6):e28885. PubMed ID: 35671089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Qualitative Exploration of Women's Experiences with a Community Health Volunteer-Led Cervical Cancer Educational Module in Migori County, Kenya.
    Choi Y; Oketch SY; Adewumi K; Bukusi E; Huchko MJ
    J Cancer Educ; 2020 Feb; 35(1):36-43. PubMed ID: 30368651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
    Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
    BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
    Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
    Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
    Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.